Jaime Bartushak
Fortune : 659 931 $ au 31/05/2026
Fortune : 659 931 $ au 31/05/2026
Jaime Bartushak is the founder.
Mr. Bartushak was the Chief Financial Officer at Leonard-Meron Biosciences, Inc. since 2014.
Mr. Bartushak is the CFO, Chief Accounting & Business Officer at Citius Pharmaceuticals, Inc. since 2022.
Mr. Bartushak is the Chief Financial Officer & Treasurer at Citius Oncology, Inc. since 2024.
Education includes undergraduate and graduate degrees from New Jersey Institute of Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,89 % | 19/09/2025 | 825 000 ( 0,89 % ) | 658 350 $ | 31/05/2026 |
| 13/02/2026 | 2 414 ( 0,01 % ) | 1 581 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CITIUS PHARMACEUTICALS, INC. | Directeur Financier/CFO | 27/11/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
Leonard-Meron Biosciences, Inc.
Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company that develops and commercializes critical care products | Fondateur | 01/11/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Operates as a pharmaceutical company | Health Technology |
New Jersey Institute of Technology
New Jersey Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leonard-Meron Biosciences, Inc.
Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company that develops and commercializes critical care products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national